These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1207413)

  • 21. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L; Cecconi C; Barbieri O; Carnemolla B; Picca M; Santi L
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some abnormal permeability characteristics of Ehrlich ascites tumor cells.
    Kiesow LA
    Z Klin Chem Klin Biochem; 1968 Jun; 6(4):309-13. PubMed ID: 5728058
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolism of 4-hydroxynonenal, a lipid peroxidation product, is dependent on tumor age in Ehrlich mouse ascites cells.
    Siems WG; Grune T; Beierl B; Zollner H; Esterbauer H
    EXS; 1992; 62():124-35. PubMed ID: 1450580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of elaidic acid incorporation upon the lipid composition of Ehrlich Ascites tumor cells and of the host's liver.
    Awad AB
    Lipids; 1978 Dec; 13(12):850-9. PubMed ID: 750825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 Apr; 54(4):881-6. PubMed ID: 123966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid oxidation to H2O by Ehrlich ascites carcinoma in mice.
    Ookhtens M; Baker N
    Cancer Res; 1979 Mar; 39(3):973-80. PubMed ID: 427783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of plasma-free fatty acid mobilization by dietary glucose in Ehrlich ascites tumor-bearing mice.
    Baker N; Hill V; Ookhtens M
    Cancer Res; 1978 Aug; 38(8):2372-7. PubMed ID: 667834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc deficiency and growth of Ehrlich ascites tumor.
    Minkel DT; Dolhun PJ; Calhoun BL; Saryan LA; Petering DH
    Cancer Res; 1979 Jul; 39(7 Pt 1):2451-6. PubMed ID: 445445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular species of glycerolipids of Ehrlich ascites cells and of their fat granules.
    Myher JJ; Kuksis A; Pind S; Kay ER
    Lipids; 1988 May; 23(5):398-404. PubMed ID: 3412116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of free fatty acids from Ehrlich ascites tumor cells.
    Spector AA; Steinberg D
    J Lipid Res; 1966 Sep; 7(5):649-56. PubMed ID: 5971046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
    Skovsgaard T
    Biochem Pharmacol; 1977 Feb; 26(3):215-22. PubMed ID: 14644
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification of the Ehrlich ascites tumor cell nuclear lipids.
    Awad AB; Spector AA
    Biochim Biophys Acta; 1976 Nov; 450(2):239-51. PubMed ID: 990304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin's effects on sialic acid level and sialidase activity in Ehrlich ascites tumor bearing mice.
    Ozen N; Uslu E; Ozen M; Aydin S; Altug T; Belce A; Kokoglu E
    Tohoku J Exp Med; 2002 Aug; 197(4):221-7. PubMed ID: 12434997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipolytic activity in adipose tissue of mice bearing Ehrlich ascites carcinoma.
    Bálint Z
    Cancer Biochem Biophys; 1991 Jun; 12(1):45-52. PubMed ID: 1769004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuation of lipid content in Ehrlich carcinoma cells during the growth period.
    Saito T; Wakui A; Kikkawa JI; Kudo T; Kikuchi K
    Tohoku J Exp Med; 1972 Sep; 108(1):63-77. PubMed ID: 4648392
    [No Abstract]   [Full Text] [Related]  

  • 38. Competition for host essential and nonessential fatty acids by Ehrlich ascites carcinoma in mice.
    Baker N; Sandborg C; Morris D; Ookhtens M
    Cancer Res; 1977 Jul; 37(7 Pt 1):2218-25. PubMed ID: 861947
    [No Abstract]   [Full Text] [Related]  

  • 39. Energetics of Na+-dependent amino acid co-transport in Ehrlich ascites tumor cells.
    Dawson WD; Smith TC
    Biochim Biophys Acta; 1987 Feb; 897(1):5-13. PubMed ID: 3801480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Net increase of lipid fatty acid in Ehrlich ascites carcinoma during growth.
    Baker N; Mermier P; Wilson L
    Lipids; 1973 Jul; 8(7):433-6. PubMed ID: 4724020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.